Edesa Biotech, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2015 | $-4.4M | $-4.7M | $274.6K | $267.2K |
| FY2016 | $-4.5M | $-4.9M | $402.3K | $259.4K |
| FY2017 | $-4.7M | $-5.0M | $302.7K | $115.5K |
| FY2018 | $-4.6M | $-1.3M | $382.8K | $81.3K |
| FY2020 | $-5.0M | $-5.0M | $4.9K | $598.4K |
| FY2021 | $-13.7M | $-13.7M | $6.1K | $3.2M |
| FY2022 | $-12.3M | $-12.3M | $5.7K | $2.3M |
| FY2023 | $-6.6M | $-6.6M | $0 | $1.2M |
| FY2024 | $-4.9M | $-4.9M | — | $537.5K |